Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
DRIO 
DarioHealth Corp (DRIO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: DRIO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $25.5
1 Year Target Price $25.5
| 3 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -61.41% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.85M USD | Price to earnings Ratio - | 1Y Target Price 25.5 |
Price to earnings Ratio - | 1Y Target Price 25.5 | ||
Volume (30-day avg) 4 | Beta 1.11 | 52 Weeks Range 5.93 - 31.00 | Updated Date 09/16/2025 |
52 Weeks Range 5.93 - 31.00 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -13.4 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -162.73% | Operating Margin (TTM) -171.35% |
Management Effectiveness
Return on Assets (TTM) -22.55% | Return on Equity (TTM) -66.92% |
Valuation
Trailing PE - | Forward PE 1.96 | Enterprise Value 25673859 | Price to Sales(TTM) 0.55 |
Enterprise Value 25673859 | Price to Sales(TTM) 0.55 | ||
Enterprise Value to Revenue 0.95 | Enterprise Value to EBITDA -0.59 | Shares Outstanding 2399830 | Shares Floating 1993540 |
Shares Outstanding 2399830 | Shares Floating 1993540 | ||
Percent Insiders 18.32 | Percent Institutions 14.7 |
Upturn AI SWOT
DarioHealth Corp
Company Overview
History and Background
DarioHealth Corp., founded in 2011, is a digital health company transforming chronic disease management. Initially focused on diabetes management, it has expanded to address multiple chronic conditions.
Core Business Areas
- Diabetes Management: Offers a comprehensive, personalized digital therapeutic solution for individuals with diabetes, including blood glucose monitoring, personalized insights, and coaching.
- Hypertension Management: Provides a digital hypertension management program, including blood pressure monitoring, personalized coaching, and insights.
- Weight Management: Delivers a weight management program that includes personalized coaching, tracking, and insights to help individuals achieve their weight loss goals.
- Musculoskeletal (MSK) Health: Offers a digital MSK solution providing personalized exercise programs, education, and support to help individuals manage pain and improve function.
- Mental Health: Provides access to virtual cognitive behavioral therapy programs and support to address mental health needs.
Leadership and Structure
The leadership team includes Erez Raphael (CEO). The company has a functional organizational structure with departments focused on technology, product development, sales, and marketing.
Top Products and Market Share
Key Offerings
- Dario Blood Glucose Monitoring System: A compact, all-in-one blood glucose monitoring system paired with a digital platform for tracking, insights, and personalized support. Market share is relatively small; competitors include Dexcom (DXCM) and Abbott (ABT). Estimated revenue from product is a portion of the total $24 million revenue.
- Dario Engage (Digital Therapeutics Platform): A comprehensive digital health platform offering personalized coaching, insights, and support for managing diabetes, hypertension, weight management, MSK and mental health. Revenue is based on subscription model.
Market Dynamics
Industry Overview
The digital health market is rapidly growing, driven by the increasing prevalence of chronic diseases, technological advancements, and demand for personalized healthcare solutions.
Positioning
DarioHealth Corp is positioned as a provider of integrated digital therapeutic solutions for chronic disease management, with a focus on personalized engagement and data-driven insights. Competitive advantages include its all-in-one device, comprehensive platform, and focus on multiple conditions.
Total Addressable Market (TAM)
The global digital health market is projected to reach hundreds of billions USD. DarioHealth is positioned to capture a small piece of this TAM through expansion and multiple chronic conditions.
Upturn SWOT Analysis
Strengths
- Comprehensive digital health platform
- Integrated device and software solution
- Personalized engagement and coaching
- Focus on multiple chronic conditions
- Strong brand presence in specific areas
Weaknesses
- Limited market share compared to larger competitors
- Reliance on partnerships for distribution
- High marketing expenses
- Limited brand awareness among all patients
Opportunities
- Expanding into new chronic conditions
- Growing partnerships with healthcare providers and payers
- Increasing adoption of digital health solutions
- International expansion
Threats
- Competition from larger, established players
- Regulatory changes and reimbursement challenges
- Data security and privacy concerns
- Slow adoption of digital health solutions by some populations
Competitors and Market Share
Key Competitors
- DXCM
- ABT
- TDOC
- LVGO
Competitive Landscape
DarioHealth Corp. competes with larger companies with more resources. Its strengths include a complete platform, user engagement, and device integration. Its weaknesses include competition from bigger firms.
Major Acquisitions
PsychoSolutions
- Year: 2021
- Acquisition Price (USD millions): 18
- Strategic Rationale: Expanded mental health offerings
Upright Technologies
- Year: 2021
- Acquisition Price (USD millions): 31
- Strategic Rationale: Entry into Musculoskeletal (MSK) market and improved DarioHealth's market position
Growth Trajectory and Initiatives
Historical Growth: DarioHealth Corp has experienced revenue growth in recent years. Historical data should be available from annual reports.
Future Projections: Future growth projections vary based on analyst estimates. Look for sources like Yahoo Finance for estimated revenues in future years.
Recent Initiatives: Recent initiatives include expanding partnerships with health systems, launching new digital health programs, and international expansion.
Summary
DarioHealth is a small but growing digital health company focusing on chronic disease management. It has a comprehensive platform and integrated device solution; however, it faces competition from large and established players with more resources. It is focused on revenue growth through partnerships and expansion into new areas. Management also needs to work on improving profitability to ensure the long-term success of the company.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Third-party market research reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market data may vary and is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DarioHealth Corp
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2014-10-06 | CEO & Director Mr. Erez Raphael | ||
Sector Healthcare | Industry Health Information Services | Full time employees 196 | Website https://www.dariohealth.com |
Full time employees 196 | Website https://www.dariohealth.com | ||
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.